Stay updated on Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:39:36.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a Phase II trial for Pembrolizumab in advanced lung cancer, while adding a new interventional model and a revision number update.
    Difference
    52%
    Check dated 2025-04-16T01:12:47.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 24, 2025.
    Difference
    0.2%
    Check dated 2025-04-08T19:40:13.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to include helpful links provided by the Spanish Lung Cancer Group, offering users more information about Fundación GECP studies. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    0.7%
    Check dated 2025-04-01T13:36:45.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new results and definitions related to the efficacy of Pembrolizumab re-challenge for advanced NSCLC, including specific survival metrics and updated reporting dates. Additionally, some outdated information has been removed, including previous results and definitions.
    Difference
    16%
    Check dated 2025-03-25T04:45:34.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice about heavy traffic affecting certain services and products, as well as a message indicating that no results were posted. Additionally, a new entry stating 'Results Submitted' has been added.
    Difference
    1%
    Check dated 2025-02-24T14:57:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced NSCLC: 2nd Line Clinical Trial page.